Table 5.

Summary of Anti‐Teduglutide Antibodies

Time point	n (%)
Baseline	N = 89
Negative	88 (98.8)
Positive	1 (1.1)
Neutralizing antibodies present	0
Week 12	n = 37
Negative	37 (100.0)
Positive	0
Neutralizing antibodies present	0
Week 24	n = 66
Negative	56 (84.8)
Positive	10 (15.2)
Neutralizing antibodies present	4 (6.1)
Week 36	n = 57
Negative	38 (66.7)
Positive	19 (33.3)
Neutralizing antibodies present	0
Week 48	n = 46
Negative	30 (65.2)
Positive	16 (34.8)
Neutralizing antibodies present	2 (4.3)
Week 60	n = 29
Negative	24 (82.8)
Positive	5 (17.2)
Neutralizing antibodies present	2 (6.9)
Week 72	n = 10
Negative	7 (70.0)
Positive	3 (30.0)
Neutralizing antibodies present	1 (10.0)
Week 84	n = 3
Negative	2 (66.7)
Positive	1 (33.3)
Neutralizing antibodies present	1 (33.3)